Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Karolinska Institutet: Two COVID-19 Vaccine Doses Increase Airway Antibodies After Infection

10/20/2021 | 04:44am EST


ę MT Newswires 2021
All news about ASTRAZENECA PLC
12:37pOdyssey buys drugmaker BenevolentAI in Europe's biggest SPAC deal
RE
12:37pOdyssey buys drugmaker BenevolentAI in Europe's biggest SPAC deal
RE
06:31aOdyssey Acquisition, BenevolentAI Sign Biggest European SPAC Merger Deal Worth $1.7 Bil..
MT
05:57aNovartis working on pan-coronavirus oral treatment, CEO says
RE
05:33aLONDON STOCK EXCHANGE : Reports of milder Omicron symptoms reassure investors
02:06aCovid-19 Vaccination - Federal Govt Approves Booster Dose
AQ
01:21aPfizer accused of funding anti- AstraZeneca info
AQ
01:00aCOVID shots are finally arriving, but Africa can't get them all into arms
RE
12:30aWhat you need to know about the coronavirus right now
RE
12:30aWhat you need to know about the coronavirus right now
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 926 M - -
Net income 2021 2 827 M - -
Net Debt 2021 25 337 M - -
P/E ratio 2021 36,6x
Yield 2021 2,54%
Capitalization 172 B 172 B -
EV / Sales 2021 5,49x
EV / Sales 2022 4,49x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 110,91 $
Average target price 137,71 $
Spread / Average Target 24,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC14.19%167 779
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641